Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neuroblastoma 2Meningioma 2Medulloblastoma 2Neuroendocrine Tumors 1Malnutrition 1Liver Failure 1Fibrosis 1Carcinoma, Hepatocellular 1

Interventions

Pentoxifylline 3Tocopherols 2tremelimumab 1ruxolitinib 1maltodextrin 1durvalumab 1atezolizumab 1Vitamin E 1Sunitinib 1Standard of Care 1Specimen Handling 1Simvastatin 1Pravastatin 1Physical Therapy Modalities 1Pharmaceutical Preparations 1Magnetic Resonance Spectroscopy 1Losartan 1Liver Transplantation 1Ketoprofen 1Hyperbaric Oxygenation 1Bevacizumab 1Amino Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Fibrosis × Amino Acids × Clear all
NCT03908255 2022-01-28

BCAA in HCC

Louisiana State University Health Sciences Center in New Orleans

Phase 2 Withdrawn
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Liver Failure, Malnutrition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡